Efficacy of the Novel Regimen Pemetrexed-Zanubrutinib in a Patient with Chronic Lymphocytic Leukemia and Central Nervous System Diffuse Large B Cell Lymphoma Presenting as Richter’s Transformations Transformation
British Journal of Cancer Research · 20.03.2025 · 8 (2)
DOI: 10.31488/bjcr.207 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Cancer Research, online erschienen am 20.03.2025. Verfasst von Julia Steger.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Steger, J. (2025). Efficacy of the Novel Regimen Pemetrexed-Zanubrutinib in a Patient with Chronic Lymphocytic Leukemia and Central Nervous System Diffuse Large B Cell Lymphoma Presenting as Richter’s Transformations Transformation. British Journal of Cancer Research, 8(2). https://doi.org/10.31488/bjcr.207
Vancouver
Steger J. Efficacy of the Novel Regimen Pemetrexed-Zanubrutinib in a Patient with Chronic Lymphocytic Leukemia and Central Nervous System Diffuse Large B Cell Lymphoma Presenting as Richter’s Transformations Transformation. British Journal of Cancer Research. 2025;8(2). doi:10.31488/bjcr.207
BibTeX
@article{Steger2025,
author = {Steger, Julia},
title = {Efficacy of the Novel Regimen Pemetrexed-Zanubrutinib in a Patient with Chronic Lymphocytic Leukemia and Central Nervous System Diffuse Large B Cell Lymphoma Presenting as Richter’s Transformations Transformation},
journal = {British Journal of Cancer Research},
year = {2025},
volume = {8},
number = {2},
doi = {10.31488/bjcr.207}
}
EUVIMED